Homolka J, Krejbich F, Mazánková V
I. klinika tuberkulózy a respiracních nemocí 1, LF UK a VFN, Praha.
Cas Lek Cesk. 2005;144(9):587-91.
The number of notified TB cases in the Czech Republic continued to decrease in the year 2004. 1057 new TB cases and relapses of TB were reported in the year 2004 (10.3 / 100,000). 861 were pulmonary TB (8.4 / 100,000) and from those 584 were unequivocal pulmonary TB cases (5.7 / 100,000). The decreasing trend in TB incidence reported since 1998 has continued. Treatment success was present in 76.7% of cases; failures and interrupted treatment were observed in only 2.0%. Results of the treatment were affected by great numbers of deaths for other causes then TB, because they were observed in the oldest part of population. The resistance for AT drugs was confirmed in less than 6% of cases and MDR-cases were under 2%. The low level of resistance and good treatment outcomes are very important for further decline of new TB cases. The next target of TB control should be the active case finding in high-risk groups and monitoring latent TB infection.
2004年,捷克共和国报告的结核病病例数量持续下降。2004年共报告了1057例新的结核病病例和复发病例(10.3/10万)。其中861例为肺结核(8.4/10万),其中584例为明确的肺结核病例(5.7/10万)。自1998年以来报告的结核病发病率下降趋势仍在持续。76.7%的病例治疗成功;仅2.0%的病例治疗失败或治疗中断。由于在老年人群中观察到大量因结核病以外其他原因导致的死亡,治疗结果受到了影响。对一线抗结核药物的耐药率在不到6%的病例中得到证实,耐多药病例低于2%。低耐药水平和良好的治疗效果对于新结核病病例的进一步下降非常重要。结核病控制的下一个目标应该是在高危人群中积极发现病例并监测潜伏性结核感染。